Complete Response Letter Received from FDA Posted on October 6, 2021January 26, 2023 by Amanda Monroe
Polarean Announces NDA Submission of 129Xenon Gas MRI Posted on October 7, 2020January 26, 2023 by Amanda Monroe
Positive Results Announced from Pivotal Phase III Clinical Trials Posted on January 29, 2020January 26, 2023 by Amanda Monroe
